## ISRG: Intuitive Surgical, Inc. - XLV: Healthcare

### Executive Summary

No thesis match: MRS_20 -0.6% below STRENGTH zone (4.0-10.0%); PEG 3.55 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (58% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($550.44)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Intuitive Surgical (ISRG): Revisiting Valuation After a 25% Three-Month Share Price Rally**
- Source: Simply Wall Street | 20251204T085944 | Somewhat-Bullish | Relevance: 100%
- Intuitive Surgical (ISRG) has seen its share price rally by about 25% over the past three months, prompting a re-evaluation of its valuation. While a fair value narrative suggests it's 3.9% undervalued at $592.96 due to innovation and growth prospects, other metrics show it trading at a significantly higher PE ratio than its industry and peers. Investors need to weigh the strong growth story against potential valuation risks and intense competition.

**2. Intuitive Surgical (ISRG) Declined Due to Managementâ€™s Cautious Commentary**
- Source: Yahoo! Finance Canada | 20251203T135200 | Somewhat-Bearish | Relevance: 100%
- Intuitive Surgical (ISRG) stock declined despite strong second-quarter results and raised full-year procedure guidance. The decline is attributed to management's cautious commentary on the European capital expenditure environment and conservative forward margin guidance, impacting investor sentiment. Brown Advisory's Large-Cap Growth Strategy noted this in its Q3 2025 investor letter, while also mentioning the strategic choice to underweight highly speculative AI stocks.

**3. Brown Advisory Inc. Has $850.95 Million Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251205T101206 | Bullish | Relevance: 100%
- Brown Advisory Inc. reduced its stake in Intuitive Surgical, Inc. by 4.6% during the second quarter, now holding 1,565,907 shares valued at $850.95 million. Other institutional investors have also adjusted their positions in the medical equipment provider, which holds a "Moderate Buy" consensus rating from analysts with an average target price of $607.17. The company recently reported strong earnings, beating analyst estimates, and has seen notable insider selling.

**4. Beacon Pointe Advisors LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251205T090047 | Somewhat-Bullish | Relevance: 100%
- Beacon Pointe Advisors LLC significantly increased its stake in Intuitive Surgical, Inc. by 48.8% in Q2, raising its holdings to 6,185 shares valued at $3.36 million. This increase ininstitutional investment comes amidst recent insider selling by executives, who have collectively sold over $60 million worth of stock, yet analysts maintain a "Moderate Buy" rating with a consensus target price of $607.17 for the company. Intuitive Surgical also reported strong Q3 earnings, beating EPS estimates with $2.40 and achieving $2.51 billion in revenue.

**5. Intuitive Surgical, Inc. $ISRG Shares Bought by Baird Financial Group Inc.**
- Source: MarketBeat | 20251205T084847 | Somewhat-Bullish | Relevance: 100%
- Baird Financial Group Inc. significantly increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.6% in the second quarter, now owning 113,691 shares valued at approximately $61.8 million. This comes despite recent insider selling, where executives sold substantial blocks of shares, leading to insiders holding only 0.70% of the stock. Meanwhile, analysts maintain a "Moderate Buy" consensus rating with a target price of $607.17, following the company's strong Q3 earnings beat.

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 5 ($2.98M) |
| Sells | 13 ($5.48M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 35.6% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.4% (+0.8%)
- Blackrock Inc.: 8.8% (+0.1%)
- State Street Corpora: 4.3% (-0.1%)
- Price (T.Rowe) Assoc: 3.6% (-4.4%)
- Geode Capital Manage: 2.3% (+1.0%)

### Key Risks

1. Insider selling cluster: $5.5M in recent transactions.
2. Valuation stretched: PEG 3.5x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 3.55 signals overvaluation risk, limited margin of safety. Forward P/E 59.0x stretched relative to 13% growth. Quality metrics strong (margin 29%). Balance sheet: strong liquidity (4.7x), low leverage (D/E 0.14). Institutional flow bearish (4 selling vs 5 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $207.1B |
| Beta | 1.69 |
| 52W Range | $425.00 - $616.00 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.55 |
| Forward P/E | 59.0 |
| Current P/E | 66.6 |
| YoY Growth | 12.8% |
| EPS Direction | RISING |

### Technicals

MRS_20 weakening modestly (-0.7% over 5 days). Below STRENGTH zone by 4.6pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.4%) - potential reversal signal. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-2.46), momentum weakening. Volume at 58% of 20MA suggests lack of conviction. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.58% (CS: 49) | Neutral |
| RSI_14 | 63.5 | Neutral |
| MACD Histogram | -2.46 | Bearish |
| vs SMA20 | 1.017x | Above |
| vs SMA50 | 1.115x | Above |
| vs SMA200 | 1.131x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $575.34
- **Stop Loss:** $550.44 (4.3% risk)
- **Target:** $600.24 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 20
- **Position Value:** $11,506.80
- **Portfolio %:** 11.51%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with balanced risk appetite. VIX near 15th percentile of 52-week range signals calm conditions, while modest yield curve steepening (54bps 10Y-3M) suggests healthy growth expectations. Breadth at 52% indicates selective participation rather than broad-based momentum.*

### Earnings

**Next:** 2026-01-22 (Est: $2.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.99 | $2.40 | +20.7% |
| 2025Q2 | $1.92 | $2.19 | +14.1% |
| 2025Q1 | $1.73 | $1.81 | +4.4% |
| 2024Q4 | $1.79 | $2.21 | +23.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*